AXSM vs STT · rev $409.6M vs P/E 17, rev $7.84B
Axsome Therapeutics Inc (AXSM) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
AXSM currently screens at market cap $11.96B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the AXSM and STT stock pages for the full models.
Not investment advice.